Basel Medical Group Ltd (NASDAQ:BMGL) Stock Short Interest Jumps 1,917.0%

Basel Medical Group Ltd (NASDAQ:BMGL) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 159,585 shares, a growth of 1,917.0% from the August 31st total of 7,912 shares. Based on an average trading volume of 3,135,507 shares, the days-to-cover ratio is currently 0.1 days. Currently, 10.1% of the shares of the company are short sold.

Basel Medical Group Stock Performance

Shares of NASDAQ:BMGL opened at $3.70 on Friday. Basel Medical Group has a 52 week low of $3.68 and a 52 week high of $22.20. The company has a 50-day moving average price of $5.13 and a 200 day moving average price of $6.53. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.83 and a current ratio of 1.88.

Basel Medical Group (NASDAQ:BMGL) last released its earnings results on Friday, June 26th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $3.21 million for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, September 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.